- Capital Cube•11 hours ago
Categories: Yahoo Finance Get free summary analysis Resverlogix Corp. reports financial results for the quarter ended July 31, 2016. Analysis Summary numbers: Revenues of CAD 0 million, Net Earnings of CAD -8.40 million. The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless. RVX-CA‘s book value ... Read more (Read more...)
- Zacks Small Cap Research•6 days ago
On September 14, Resverlogix Corp. (RVX.TO) submitted its financial filings for its first quarter of fiscal year 2017 ending July 31, 2016 to the Alberta Securities Commission. The company reported no revenues and a net loss of ($6.5) million or ($0.06) per share. This compares to our estimates also of zero revenues and a net loss of ($4.4) million or ($0.04) per share. Total operational expenses for 1Q:17 were $7.1 million, increasing from $3.5 million in the same quarter of the prior year. First quarter research & development expenses rose 183%, while general & administrative fell 27%. Costs related to the BETonMACE clinical trial drove the overall increase.
- PR Newswire•13 days agoResverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & Analysis
CALGARY, Sept. 14, 2016 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has filed its unaudited interim Consolidated Financial Statements ...
Resverlogix Corp. (RVX.TO)
Toronto - Toronto Delayed Price. Currency in CAD
|Day's Range||1.65 - 1.76|
|52wk Range||1.10 - 2.52|
|1y Target Est||N/A|
|P/E Ratio (ttm)||-6.20|
|Avg Vol (3m)||34,960|
|Dividend & Yield||N/A (N/A)|